Theranostics Market Size is Estimated to Reach US$ 3,096.47 Million by 2032 | Study By Polaris Market Research

The global Theranostics Market was valued at US$ 1,212.39 Million in 2022. Looking forward, Polaris Market Research anticipates the market to reach US$ 3,096.47 Million by 2032, exhibiting a CAGR of 10.1% during the forecast period. The rising incidences of cancer and other chronic conditions across the globe primarily fuel the market growth.

Theranostics is an emerging field of medicine that integrates diagnostic and therapeutic techniques into a single approach. It aims to develop tailored treatments for individual patients.

Download Our Sample Report for Key Insights into the US$ 3,096.47 Million Theranostics Market! https://www.polarismarketresearch.com/industry-analysis/global-theranostics-market/request-for-sample

These treatment plans are based on the biological and disease profiles of individual patients. The field uses diagnostic techniques for the identification of specific biomarkers or genetic signatures linked with the disease.

The information is then utilized to create the most apt therapeutic plan involving therapeutic drugs and various other modalities. Theranostics has garnered significant traction over the past few years, especially in the fields of neurology, cardiology, oncology, and immunology.
Competitive Insights

The market for theranostics has the presence of both new entrants and top industry participants. Some of the major players operating in the market are:

1. F Hoffman La Roche
2. Thermo Fisher Scientific Inc.
3. GE Healthcare
4. Qiagen NV
5. Agilent Technologies
6. Leica Biosystems Nussloch GmBH
7. Pfizer, Inc.
8. Foundation Medicine

Get Ahead with Detailed Regional Market Insights: Purchase Now to Access Segment-specific Information, Uncover Key Trends, Drivers, and regional outlook! https://www.polarismarketresearch.com/buy/129/2

Growth Aspects and Opportunities

With the rising prevalence of cancer worldwide, there is increased demand for personalized medicine and effective treatments. Along with creating personalized therapeutic plans, theranostics can assist in the identification of specific biomarkers. This, in turn, impacts the market demand favorably. Besides, advances in technology is the second most important factor for the development of the industry.

Segmental Overview:
Polaris Market Research has segmented the theranostics Market report based on disease, technology, end-user, and region:

Theranostics Market, Disease Outlook (Revenue - USD Million, 2019 - 2032)

• Neurological Disorders
• Cardiovascular Diseases
• Oncology Disorders
• Immunological Disorders

Theranostics Market, Technology Outlook (Revenue - USD Million, 2019 - 2032)

• Polymerase Chain Reaction (PCR)
• In Situ Hybridization (ISH)
• Immunohistochemistry (IHC)
• Sequencing

Theranostics Market, End-User Outlook (Revenue - USD Million, 2019- 2032)

• Hospitals and Clinics
• Diagnostics Laboratories
• Others

𝐍𝐨𝐰 𝐭𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐒𝐞𝐠𝐦𝐞𝐧𝐭-𝐬𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧, 𝐔𝐧𝐜𝐨𝐯𝐞𝐫 𝐊𝐞𝐲 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐃𝐫𝐢𝐯𝐞𝐫𝐬, 𝐚𝐧𝐝 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤! https://www.polarismarketresearch.com/industry-analysis/global-theranostics-market

Theranostics Market, Regional Outlook (Revenue - USD Million, 2019 - 2032)

 North America
o U.S.
o Canada
 Europe
o Germany
o UK
o France
o Italy
o Spain
o Russia
o Netherlands
 Asia Pacific
o China
o India
o Japan
o South Korea
o Indonesia
o Malaysia
 Latin America
o Argentina
o Brazil
o Mexico
 Middle East & Africa
o UAE
o Saudi Arabia
o Israel
o South Africa

Regional Insights:

The theranostics market shows promising growth across different regions globally. North America leads the market due to advanced healthcare infrastructure, high R&D investments, and increasing adoption of personalized medicine.

Europe follows closely with a strong emphasis on precision medicine and favorable government initiatives. In Asia-Pacific, rapid urbanization, improving healthcare facilities, and rising awareness about personalized treatments are driving market expansion.

Additionally, emerging economies in Latin America and the Middle East are witnessing increasing investments in healthcare technologies, contributing to the growth of the theranostics market on a global scale.

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
Viscosupplementation Market : https://www.openpr.com/news/3453968/viscosupplementation-market-is-projected-to-grow-to-us-12-94

Dental Implants Market: https://www.openpr.com/news/3453999/dental-implants-market-is-expected-to-grow-at-a-cagr-of-8-90

Real-Time Location Systems Market: https://www.polarismarketresearch.com/industry-analysis/real-time-location-systems-market

Exhaust System Market: https://www.polarismarketresearch.com/industry-analysis/exhaust-system-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐈𝐧𝐟𝐨:
Polaris Market Research
30 Wall Street, 8th Floor,
New York City, NY 10005,
United States
Phone:+1-929 297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.